There are the SCN5A mutation-positive group with more patients with sudden death of a relative under 45 years old than the mutation-negative group (p=0, 029); who has a higher rate of ventricular arrhythmias (p=0.049); with a higher rate of positive flecanide test than the mutation-negative group (p=0, 034).